Document Detail


Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man.
MedLine Citation:
PMID:  8082507     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cholesterol gallstones form frequently among obese patients during rapid loss of weight. The aims of the present study were to determine the short-term natural history of these gallstones and the efficacy of ursodiol for their dissolution. Twenty-two patients whose gallstones had formed during rapid loss of weight were randomized in double-masked fashion to either ursodiol, 1200 mg/day, or placebo for nine months. Ultrasonography of the gallbladder was performed after three and nine months of treatment. All patients without disappearance of their gallstones after nine months received open-label ursodiol for an additional nine months with ultrasonography after three and nine months. Among the patients completing three months of masked treatment, disappearance of gallstones was seen in five of 11 patients who received placebo and four of seven patients who received ursodiol. Only one additional patient of six continuing placebo for nine months experienced disappearance. Neither of two patients continuing ursodiol for nine months had disappearance of gallstones. None of the five patients treated with open-label ursodiol for nine months had disappearance of gallstones. Thus, half of the gallstones that form during rapid loss of weight disappear rapidly once loss of weight ceases; ursodiol may not increase the frequency or rapidity of their disappearance.
Authors:
J W Marks; T Stein; L J Schoenfield
Related Documents :
18266577 - Hand-assisted laparoscopic nephroureterectomy (halnu): an assessment of the impact of o...
17933547 - A prospective analysis of the inter-relationship between lung volume reduction surgery ...
19705207 - Long-term nutritional outcome after gastric bypass.
11975227 - Binge eating among gastric bypass patients at long-term follow-up.
21546777 - Mild and severe anal incontinence after lateral internal sphincterotomy: risk factors, ...
10207437 - Symptomatic lumbar facet joint synovial cysts: clinical assessment of facet joint stero...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Digestive diseases and sciences     Volume:  39     ISSN:  0163-2116     ISO Abbreviation:  Dig. Dis. Sci.     Publication Date:  1994 Sep 
Date Detail:
Created Date:  1994-10-13     Completed Date:  1994-10-13     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7902782     Medline TA:  Dig Dis Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1981-4     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, UCLA School of Medicine.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cholelithiasis / drug therapy*,  etiology,  ultrasonography
Double-Blind Method
Female
Humans
Male
Middle Aged
Treatment Outcome
Ursodeoxycholic Acid / therapeutic use*
Weight Loss / physiology*
Grant Support
ID/Acronym/Agency:
AM 37080/AM/NIADDK NIH HHS
Chemical
Reg. No./Substance:
128-13-2/Ursodeoxycholic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CCK-receptor antagonists proglumide and loxiglumide stimulate bile flow and biliary glutathione excr...
Next Document:  Hepatoduodenal bile transit in cholecystectomized subjects. Relationship with sphincter of Oddi func...